About this trial
This study uses the Physical Frailty Phenotype (PFP) as the diagnostic criterion for frailty and aims to explore the frailty screening scale FRAIL (The FRAIL Scale), Tilburg Frailty Index (TFI) and geriatric screening. Screening performance of Tool-8 (Geriatric-8, G-8) in breast cancer patients, to compare the predictive validity of different frailty screening scales for adverse health outcomes in breast cancer patients, and to select appropriate frailty screening methods for breast cancer patients in my country Screening scale.
Eligibility criteria
Qualifiers
Clinical diagnosis of breast cancer
Age ≥50 years old
the treatment plan discussed by MDT includes surgery and chemotherapy
can walk on their own (with the assistance of walking aids)
Disqualifiers
Communication disorders
Mental disorders that can't cooperate normally
Combined with other malignant tumours
Terminal stage of the disease
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Ju Qiu
Lead sponsor
Chongqing Medical University
Sponsor institution
Ministry of Education, China
Collaborator